Details for New Drug Application (NDA): 008248
✉ Email this page to a colleague
NDA 008248 describes WYAMINE SULFATE, which is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. Additional details are available on the WYAMINE SULFATE profile page.
The generic ingredient in WYAMINE SULFATE is mephentermine sulfate. There is one drug master file entry for this compound. Additional details are available on the mephentermine sulfate profile page.
The generic ingredient in WYAMINE SULFATE is mephentermine sulfate. There is one drug master file entry for this compound. Additional details are available on the mephentermine sulfate profile page.
Summary for 008248
| Tradename: | WYAMINE SULFATE |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | mephentermine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008248
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 30MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 15MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
